News

Five events make for a busy summer in retina

In the Lucentis biosimilars wars, there are no winners so far

Study reports potential of OCT to identify vascular damage in severe COVID-19

With FDA approval, pegcetacoplan launches with high awareness—and a few questions

Why are ophthalmologists a definite maybe about biosimilars? Survey provides answers

A deeper dive into anti-VEGF loss to follow-up: Study identifies risk factors

Where are the women in retina? Not at the podium, study reports

Bevacizumab first, aflibercept second cost-effective for DME, Protocol AC finds

With Byooviz, Biogen takes a leap on pricing first U.S. retina biosimilar

New DME treatment trial targets underrepresented populations

Current Issue

Retina Specialist
Table of Contents Digital Edition PDF Edition Archives Subscription

Continuing Medical Education

Breaking New Ground: Reducing Treatment Burden in nAMD
Breaking New Ground: Reducing Treatment Burden in nAMD CME Monograph
View More CME

Additional Publications

Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
View More Publications

Review Of Ophthalmology

Review of Ophthalmology
Table of Contents Digital Edition PDF Edition Archives Subscription

Video Vault

Minimally invasive management of lenticular deposits

Akshay Thomas, MD, MS, of Tennessee Retina demonstrates his surgical technique for removing posterior intraocular lens deposits.